Multiple Myeloma

Videos

When to Consider Second Autologous Transplant for Patients With Relapsed Multiple Myeloma

03/22/2019

Andrew J. Cowan, MD, explains when physicians should consider a second autologous stem cell transplant for patients with relapsed multiple myeloma.

Andrew J. Cowan, MD, explains...

03/22/2019

Oncology

Novel Small Molecule Inhibitors Show Promise in the Treatment of Multiple Myeloma

03/22/2019

Joseph Mikhael, MD, MEd, FRCPC, discussed novel small molecule inhibitors in multiple myeloma.

Joseph Mikhael, MD, MEd, FRCPC,...

03/22/2019

Oncology

Podcasts

Quadruplet Therapy Yields Promising Results in Newly Diagnosed MM

12/26/2018

Shaji Kumar, MD, discusses the significance of a trial presented at ASH that involved an MM therapy comprising ixazomib, lenalidomide, dexamethasone, and daratumumab.

Shaji Kumar, MD, discusses the...

12/26/2018

Oncology

Multi-Class Drug Combo Shows Promise in Newly Diagnosed MM

12/13/2018

A combination regimen comprised of multiple drug classes has produced rapid and deep responses in patients with newly diagnosed multiple myeloma.

A combination regimen comprised...

12/13/2018

Oncology

Combo Therapy for Smoldering MM Yields Promising Results

12/13/2018

Therapy with elotuzumab plus lenalidomide and dexamethasone was tolerable and led to high response rates in patients with high-risk smoldering multiple myeloma.

Therapy with elotuzumab plus...

12/13/2018

Oncology

Videos

Genomic Testing and Tailored Therapies for Multiple Myeloma

12/13/2018

Joseph Mikhael, MD, MEd, FRCPC, spoke to Oncology Learning Network about genomic testing in multiple myeloma and how it can help clinicians personalize treatments for patients. He also shared his favorite analogy for using targeted therapy in...

Joseph Mikhael, MD, MEd, FRCPC,...

12/13/2018

Oncology

News

New CAR-T Therapy Less Toxic, More Effective for MM Than Other CAR-Ts

11/29/2018

P-BCMA-101, a novel CAR-T therapy, has demonstrated significant efficacy in patients with relapsed or refractory MM.

P-BCMA-101, a novel CAR-T...

11/29/2018

Oncology

The Future Treatment Landscape for Relapsed and Refractory Myeloma

10/19/2018

Kenneth C. Anderson, MD, discussed the future of the treatment landscape for patients with relapsed and refractory myeloma.

Kenneth C. Anderson, MD,...

10/19/2018

Oncology

Multiple Genetic Drivers Key to Enhancing Individualized Therapy in Multiple Myeloma

10/18/2018

It is crucial to address the genetic drivers of both multiple myeloma and its environment when individualizing treatment, according to Joseph Mikhael, MD, MEd, FRCPC.

It is crucial to address the...

10/18/2018

Oncology

Benefits of Genome Sequencing in Multiple Myeloma

10/18/2018

DNA and RNA sequencing improve personalized treatment in multiple myeloma, and are feasible and effective for relapsed disease, explained Samir Parekh, MBBS.

DNA and RNA sequencing improve...

10/18/2018

Oncology